Developing & Optimizing Synuclein PET Ligands for Imaging of Pathological Proteins in Neurodegenerative Disease

Time: 2:30 pm
day: Conference Day Two


  • Screening and discovery of small molecule ligands that bind to aggregated alpha-synuclein
  • Optimization and in vivo imaging of MK-7337 a novel PET tracer candidate
  • Clinical strategy for MK-7337 proof-of-concept studies in Parkinson’s disease patients.